Skip to main content
. 2021 Mar 3;11:634059. doi: 10.3389/fonc.2021.634059

Figure 3.

Figure 3

Association between CD8+ T cells and their subsets with survival in NSCLC. Kaplan-Meier estimates of overall survival (OS) stratified by pathological stage according to CD8+ T cells (A, B), PD-1+ CD8+ T cells (C, D), and CD38+ CD8+ T cells (E, F). (A, C, E) for all stage patients (including stages I, II, and III); (B, D, F) for middle and advanced stage patients (including stages II and III).